HealthMap

Mineral Loss in Urine During Cortisone Therapy

Cortisone and other corticosteroid medications significantly impact the body's mineral balance and excretion rates. According to Acu-Cell Nutrition principles regarding mineral interactions and drug-induced deficiencies, the primary mineral losses and imbalances associated with cortisone therapy include:

• Calcium (`Ca`)
• Major Loss: Cortisone therapy drastically reduces intestinal absorption of calcium while simultaneously increasing its excretion through the kidneys into the urine.
• Consequence: This dual action significantly increases the risk of bone density loss, osteopenia, and osteoporosis.

• Potassium (`K`)
• Major Loss: Cortico-steroids promote renal excretion of potassium, leading to significant urinary depletion.
• Consequence: Low potassium levels (hypokalemia) can result in muscle weakness, fatigue, cramping, and cardiac arrhythmias.

• Zinc (`Zn`)
• Increased Excretion: Cortisone use accelerates the loss of zinc via urinary output.
• Consequence: Depleted zinc levels can negatively impact immune function, tissue healing, and enzyme systems.

• Magnesium (`Mg`)
• Secondary Depletion: While the primary diuretic and wasting effect heavily targets potassium and calcium, magnesium is frequently lost alongside potassium due to shared renal regulatory pathways.

Important Nutritional Considerations

• Antagonistic Effects: Drugs like cortisone act as chronic antagonists to key alkaline minerals and protective trace elements.
• Supplementation Strategy: When undergoing long-term cortisone therapy, nutritional protocols typically focus on aggressively supporting and replenishing Calcium, Potassium, Magnesium, and Zinc levels to help mitigate deficiency-related side effects.